Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2D6 | P10635 | 8/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 5/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 4/20 | 1.00 |
| ▸ | TSHR | P16473 | 3/20 | 1.00 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.79 |
| ▸ | MEN1 | O00255 | 1/20 | 0.79 |
| ▸ | XBP1 | P17861 | 1/20 | 0.49 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.48 |
| ▸ | DRD1 | P21728 | 1/20 | 0.46 |
| ▸ | DRD5 | P21918 | 1/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 3/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.43 |
| ▸ | GABRP | O00591 | 1/20 | 0.43 |
| ▸ | GABRD | O14764 | 1/20 | 0.43 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.43 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.43 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.43 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29356135 | 1.00 | CYP2D6 (1.00) | CYP2D6CYP2C19CYP3A4TSHRKDM4E | |
| Hydrochloric Acid SCHEMBL4456077 | 0.99 | CYP2D6 (0.98) | CYP2D6CYP2C19CYP3A4TSHRKDM4E | |
| Hydrochloric Acid SCHEMBL29389905 | 0.99 | CYP2D6 (0.98) | CYP2D6CYP2C19CYP3A4TSHRKDM4E | |
| Nitric Acid SCHEMBL3871762 | 0.93 | CYP2D6 (0.86) | CYP2D6CYP2C19CYP3A4TSHRKDM4E | |
| SCHEMBL178039 | 0.88 | KMT2A (1.00) | CYP2D6CYP2C19CYP3A4TSHRKDM4E | |
| SCHEMBL29419477 | 0.88 | KMT2A (1.00) | CYP2D6CYP2C19CYP3A4TSHRKDM4E | |
| Stylopine SCHEMBL23524621 | 0.88 | CYP2D6 (0.77) | CYP2D6CYP2C19CYP3A4TSHRKDM4E | |
| SCHEMBL9882661 | 0.83 | CYP2D6 (0.71) | CYP2D6CYP2C19CYP3A4TSHRKDM4E | |
| Protopine SCHEMBL29613725 | 0.83 | CYP2D6 (1.00) | CYP2D6CYP2C19CYP3A4TSHRKDM4E | |
| Allocryptopine SCHEMBL673252 | 0.82 | CYP2D6 (1.00) | CYP2D6CYP2C19CYP3A4TSHRKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1891 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4714440-A2 | A HEALING HERBAL-MINERAL COMPOSITION WITH ENHANCED EFFECTS | Kurek, Janusz (PL) | 2026-03-25 | — | — | EP | claimed |
| EP-4687856-A2 | GLP-1R AGONIST AND DPP-4 INHIBITOR COMPOSITIONS AND METHODS OF USING | JDS Therapeutics, LLC (US) | 2026-02-11 | — | — | EP | claimed |
| US-12485112-B2 | Pharmaceutical composition | ASCLEPIUS PHARMACEUTICAL LLC (US) | 2025-12-02 | — | — | US | claimed |
| EP-3578542-B1 | COMPOSITIONS HAVING PESTICIDAL UTILITY AND PROCESSES RELATED THERETO | CORTEVA AGRISCIENCE LLC (US) | 2025-11-12 | — | — | EP | claimed |
| CN-120121741-A | Detection method of traditional Chinese medicine composition | 江苏康缘药业股份有限公司 | 2025-06-10 | — | — | CN | claimed |
| EP-3578541-B1 | COMPOSITIONS COMPRISING MOLECULES HAVING PESTICIDAL UTILITY, AND PROCESSES RELATED THERETO | CORTEVA AGRISCIENCE LLC (US) | 2025-05-28 | — | — | EP | claimed |
| CN-119955611-A | Fermentation system and fermentation method capable of industrially producing active proto-type Conpu tea | 贵州康普茶天然发酵饮料科技有限公司 | 2025-05-09 | — | — | CN | claimed |
| CN-119291083-B | Quality control method of jindan accessory delay particles | 江西省药品检验检测研究院 | 2025-05-02 | — | — | CN | claimed |
| CN-119901843-A | Fingerprint construction method of nodules of breast resolving capsules/particles and fingerprint thereof | 陕西白鹿制药股份有限公司 | 2025-04-29 | — | — | CN | claimed |
| CN-119745869-A | Application of Dong medicine blood herb active ingredient protopine in anti-atherosclerosis medicine | 南华大学 | 2025-04-04 | — | — | CN | claimed |
| CN-1429611-A | Greater celandine extract and its preparation method and application | ZHANG PING (CN) | 2003-07-16 | — | — | CN | claimed |
| CN-1422859-A | reaction method of alkaloid, reaction product and application thereof | HUATZ NORVICH (AT) | 2003-06-11 | — | — | CN | claimed |
| CN-1385157-A | Application of protopine in preparing medicine for treating senile dementia | KUNMING INST OF ANIMALS CHINES (CN) | 2002-12-18 | — | — | CN | claimed |
| US-20010008641-A1 | NUTRITIONALLY ACTIVE COMPOSITION FOR BODYBUILDING | ADAMS FOODS, LTD. | 2001-07-19 | — | — | US | claimed |
| CN-1280825-A | Sigma-receptor acting medicine containing protopine-type alkaloid | CHENGDU INST BIOLOGY CAS (CN) | 2001-01-24 | — | — | CN | claimed |
| WO-2000003679-A2 | NUTRITIONALLY ACTIVE COMPOSITION FOR HARDENING FINGERNAILS | ADAMS FOOD LTD. (US) | 2000-01-27 | — | — | WO | claimed |
| WO-1999061038-A1 | COMPOSITION HAVING THERAPEUTIC AND/OR NUTRITIONALLY ACTIVE SUBSTITUENT | ADAMS FOOD LTD. (US) | 1999-12-02 | — | — | WO | claimed |
| US-4769452-A | Production of purity benzo-c-phenanthridine alkaloid salts | VIPONT LABORATORIES, INC. (US) | 1988-09-06 | — | — | US | claimed |
| US-4683133-A | PUMPING ALKALOID SALT SOLUTIONS ON GUMS | VIPONT LABORATORIES, INC. (US) | 1987-07-28 | — | — | US | claimed |
| US-4590061-A | BENZO-C-PHENANTHRIDINE ALKALOIDS | VIPONT LABORATORIES, INC. (US) | 1986-05-20 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12485112-B2 | Pharmaceutical composition | H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, ADRA2C, CPT1A | CYP2D6 111/4885CYP2C19 250/4885CYP3A4 86/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.